See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2017_Biospecifics_Technologies_CORP.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000875622, Biospecifics Technologies CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,399,967 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 258,355 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 9,037,958 |
| 4 | LiabilitiesCurrent | 1,996,635 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,891,207 |
| 9 | ResearchAndDevelopmentExpense | 1,413,712 |
| 10 | remainder_Expenses | 5,949,701 |
| 11 | remainder_Revenues | 26,647,158 |
| 12 | remainder_NetIncome | 1,553,302 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 64,696,280 |
| 1 | Liabilities | 1,996,635 |
| 2 | Expenses | 15,254,620 |
| 3 | Revenues | 26,647,158 |
| 4 | StockholdersEquity | 62,699,645 |
| 5 | NetIncome | 12,945,840 |
| 6 | ComprehensiveNetIncome | 12,945,840 |
| 7 | BaseVar | 55,073,998 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.49 |
| 9 | EconomicCapitalRatio | 4.77 |
Edgar->Model Mapping
Feature Distribution
Change over Time
